Error 404
Looks like something went completely wrong. The page you are looking for cannot be found. Don't worry, just go back or browse our latest articles below.
Business & Industry
Eli Lilly and Haisco Pharmaceutical Enter $3Billion+ Deal
Eli Lilly has entered into a multi-program collaboration with Beijing-based Haisco Pharmaceutical Group, committing an upfront payment of $87 million and exposing itself to...
BioPharma
Aragen Achieves Daretabart Commercial-scale GMP Production
Aragen, a global leader in Contract Research, Development, and Manufacturing Organization (CRDMO) services, has announced the successful technology transfer and commercial-scale GMP manufacturing of...
Articles
Stevanato Group and Syntegon Join Forces to Drive Innovation
Quality first: advanced manufacturing process for EZ-fill® cartridges
The development of GLP-1 drugs has revolutionized the treatment of diabetes and obesity – and is a...
Business & Industry
Lilly Signs $1.26bn Sonefpeglutide Licensing Deal with Hanmi
Eli Lilly and Company and Hanmi Pharm have officially finalized a comprehensive licensing agreement. Under the terms of the worldwide arrangement, Sonefpeglutide licensing is...
News
Pharmacogenomics in 2026: From Research Concept to Clinical Workflow
Pharmacogenomics has moved well beyond the research phase. In 2026, healthcare systems are using genetic insights as part of routine prescribing decisions, especially in...
Business & Industry
Pfizer and Innovent Finalize $10.5 Billion Global Oncology Agreement
The Pfizer Innovent Cancer Deal has been finalized, establishing a global licensing and collaboration agreement valued at up to $10.5 billion. The transaction focuses...
BioPharma
Nestlé and IdB Partner to Bring rCDI Preventive Therapy to Europe
Nestlé Health Science and IdB Holding have officially announced a VOWST licensing agreement to develop and commercialize the oral therapy in Europe, subject to...
Business & Industry
CordenPharma Seals AmbioPharm Deal to Expand Global Network
CordenPharma, a global contract development and manufacturing organization specializing in complex drug modalities, has officially entered into an agreement to acquire AmbioPharm. The AmbioPharm...
